A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma-Reference-Cited by-同舟云学术

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Published:2015-07 Issue:7 Volume:15 Page:392-397
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Cassaday Ryan D.,Goy Andre,Advani Suresh,Chawla Purvi,Nachankar Rajesh,Gandhi Mansi,Gopal Ajay K.

Funder

National Institutes of Health

NIH

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. Mantle cell lymphoma;Pileri;Haematologica,2009

2. Advances in the understanding of mantle cell lymphoma;Jares;Br J Haematol,2008

3. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas: correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity;Jares;Am J Pathol,1996

4. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics;Jares;Nat Rev Cancer,2007

5. Novel therapeutic targets in mantle cell lymphoma;Martin;Expert Opin Ther Targets,2007

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma;Cancer Letters;2024-08

2. Identification of the potential Pan-CDK antagonists: tracing the path of virtual screening and inhibitory activity on lung cancer cells;Molecular Diversity;2024-07-29

3. Cardiovascular events associated with CDK4/6 inhibitors based on randomized controlled trials or cohort trials: a safety meta-analysis;2024-04-04

4. A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: Unlocking cellular and biochemical mechanisms;Chemico-Biological Interactions;2024-04

5. Advances in Flavonoid Research: Sources, Biological Activities, and Developmental Prospectives;Current Issues in Molecular Biology;2024-03-26